Co-Authors
This is a "connection" page, showing publications co-authored by Takaji Wakita and Taiga Miyazaki.
Connection Strength
0.416
-
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study. PLoS Med. 2021 07; 18(7):e1003660.
Score: 0.239
-
Revisiting the guidelines for ending isolation for COVID-19 patients. Elife. 2021 07 27; 10.
Score: 0.060
-
Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial. Trials. 2021 Apr 28; 22(1):309.
Score: 0.059
-
Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model. J R Soc Interface. 2021 04; 18(177):20200947.
Score: 0.059